Post-treatment neuroendocrine outcomes among pediatric brain tumor patients: Is there a difference between proton and photon therapy?
13/02/2022
/
Publications
/
Reirradiation
This study compared the neuroendocrine outcomes of 112 pediatric primary brain tumor patients treated with XRT(n = 80) or PRT (n = 32). With a median follow-up...
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy.
13/06/2022
/
Publications
This study compared the neurocognitive results of patients who received PRT (n = 38) or XRT (n = 20) at least one year after radiotherapy. This study found that...
Toxicity and Clinical Results after Proton Therapy for Pediatric Medulloblastoma: A Multi-Centric Retrospective Study.
13/06/2022
/
Publications
/
Toxicity
Pencil Beam Scanning - PBS
This study reported toxicities of 43 children with medulloblastoma treated with PBS-PT. The most common (>30% of patients) acute toxicities were radiation...
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
13/04/2023
/
Publications
/
Chemotherapy
Dosimetry
This study evaluated 68 patients with atypical teratoid/rhabdoid tumors (ATRT) treated with surgery (65% initial gross total resection or GTR), chemotherapy (60...
Gastrointestinal bleeding/ulcer among paediatric cancer patients after proton beam therapy.
13/06/2023
/
Publications
/
Reirradiation
Chemotherapy
This study analyzed 124 patients who underwent proton therapy with gastrointestinal tract involved in the irradiated field. The study reported gastrointestinal...
Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis.
13/08/2023
/
Publications
Based on 10 studies including a total 630 patients, this review reported that proton therapy produced significantly higher scores for most analyzed...
Proton therapy for pediatric diencephalic tumors.
13/05/2023
/
Publications
/
Toxicity
Tumors arise in the diencephalon including optic pathway/hypothalamic glioma, craniopharyngioma, germ cell tumors, and pituitary adenomas which tend to be low...
Proton Therapy Mediates Dose Reductions to Brain Structures Associated with Cognition in Children with Medulloblastoma.
13/11/2023
/
Publications
/
Dosimetry
This study evaluated dosimetric and cognitive data from 75 patients with medulloblastoma treated with proton (n=36) and photon (n=39). Significant dose...
MGH’s 20 Years Treating with Protons and their Important Role in Pediatrics
29/09/2021
/
Podcast
September marks Childhood Cancer Awareness Month, so this episode will focus on pediatric cancer treatment and the many ways proton therapy can benefit children...
Young Adult Populations Face Yet Another Barrier to Care with Insurers: Limited Access to Proton Therapy.
16/08/2021
/
Publications
/
Toxicity
Secondary cancer
Young adult patients (n = 68/143, 48%) were significantly less likely to receive initial approval compared with pediatric patients (n = 139/141; 99%) (P < .001)...
Cookies policy
If you continue browsing this website, you agree to the use of cookies in order to provide you with services and offers tailored to your own interests.
Manage your cookie preferences
Respect for your privacy is still a priority for us at IBA.
Functional cookies ensure that the website runs smoothly. They cannot be turned off. By setting your preferences, you can turn the use of these cookies on and off on our website, although these settings will only be valid on the device you are currently using.